Hill January 6, 2023
Congress acted last month to extend important telehealth flexibilities that will ensure millions of Americans and their providers will continue to have access to telehealth when the COVID-19 public health emergency is officially over. The importance of these policy extensions can’t be overstated. However, there is one remaining critical action item: prescribing for mental health and substance abuse treatment.
To ensure that prescribing controlled substances by telehealth can continue, the Drug Enforcement Agency (DEA) must publish a long-awaited registration process. This process is supposed to ensure patients get medications while guarding against inappropriate prescribing or rogue internet pharmacies.
The extent of the inaction by the DEA on this issue is staggering. It has been nearly 14 years since Congress required...
Today's Sponsors
Today's Sponsor